OR WAIT null SECS
November 07, 2014
ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration.
November 06, 2014
Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.
November 04, 2014
AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers.
November 03, 2014
Spectranetics announced that it acquired Covidien's drug-coated balloon platform, Stellarex, for $30 million.
November 02, 2014
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
The author reviews the challenges in delivering macromolecule biologics.
Measuring syringe plunger force using a texture analyzer instrument.
This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets.
November 01, 2014
The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.
October 31, 2014
Amgen is suing Sandoz over Sandoz's biosimilar application for filgrastim.
